Biomarkers Europe 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences
Barts Cancer Institute, Queen Mary University of London at Biomarkers Europe 2026
Oct 13–14, 2026 Basel, Switzerland ~1k attendees Website
Barts Cancer Institute, Queen Mary University of London takes part in 2 sessions at Biomarkers Europe 2026 in Basel. Its sessions cover early detection of pancreatic cancer and how investors view the future of multi-omics, the combined study of genes, proteins and other molecules. One follows pancreatic cancer detection research from the lab toward clinical use.
| Organization | Biomarkers Europe 2026 Attendance |
|---|---|
Cancer research institute of Queen Mary University of London working on early detection, tumour biology and clinical trials. | Panel Tue Oct 13 12:40pm–1:30pm Navigating The Multi-Omics Investment Landscape: How Investors See The Future Of The Field Genomics, proteomics and multi-omicsDrug–diagnostic commercialization & access Talk Tue Oct 13 2:55pm–3:20pm A Translational Journey To Pancreatic Cancer Detection Biomarker discovery & translation |
Instantly find 20 buyers from Barts Cancer Institute, Queen Mary University of London
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by Biomarkers, CDx & Precision Medicine or its organizers. Submit a correction